Flow Traders U.S.’s Pfizer PFE Stock Holding History

Flow Traders U.S.’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,703	Closed	-$390K	–	1211
2024 Q4	$390K	Buy	+14,703	New	+$399K	0.02%	669
2017 Q2	–	Sell	-14,139	Closed	-$459K	–	313
2017 Q1	$459K	Buy	+14,139	New	+$446K	0.04%	217

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Flow Traders U.S.'s PFE Position: Q1 2025 in Review

Flow Traders U.S. sold out of Pfizer (PFE) in Q1 2025, closing a stake of 14,703 shares — an estimated $390K sold.

Flow Traders U.S. first reported a position in PFE in Q1 2017 and held it in 2 quarters. The position peaked at $459K in Q1 2017. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Flow Traders U.S. reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Flow Traders U.S. sold 14,703 Pfizer shares in Q1 2025, an estimated $390K.
Flow Traders U.S. first reported a position in Pfizer in Q1 2017 and held it in 2 quarters.
Flow Traders U.S.'s Pfizer position peaked at $459K in Q1 2017.
2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Flow Traders U.S.'s 13F filing for Q1 2025, filed 14 May 2025.